Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Cost-utility analysis of azacitidine versus decitabine in the treatment of myelodysplastic syndrome

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1371-1379.
1136 times 458 times

La-Ji DANZENG Yong-Gong YANG Si-Liang WANG Meng-Ying LIU

Azacitidine Decitabine Myelodysplastic syndrome Markov model Cost-utility analysis Pharmacoeconomics
Details
Literature case analysis of hyperammonemic encephalopathy caused by sodium valproate

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1417-1424.
1150 times 406 times

Li-Yuan WANG Jing LI Zi-Hao DUAN Fa-Cai WANG Jun-Jie JIANG

Sodium valproate Hyperammonemic encephalopathy Adverse drug reactions Case analysis
Details
Pharmaceutical practice of clinical pharmacists participating in the treatment for refractory edema secondary to diabetic kidney disease

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1425-1431.
1117 times 784 times

Ze CHEN Wei TIAN Qi JIN Xian-Xi GUO Hua HU

Clinical pharmacist Drug treatment Diabetic kidney disease Refractory edema Pharmaceutical care
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):19-27.
1181 times 919 times

ZHANG Yinan WU Tingxi ZHAO Zhigang

Drug benefit-risk communication Safety communication Drug safety information Pharmacovigilance
Details
A case of sudden cardio arrest caused by oxaliplatin injection

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1316-1320.
1487 times 598 times

Ying WANG Qin-Yong SHEN Shan HUANG Bing LIN Ai-Wen HUANG

Oxaliplatin Sudden cardio arrest Allergic reaction Adverse drug reaction
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1311-1315.
1469 times 476 times

Jin-Jin ZOU Ji-Liang ZHANG Ni LI Ding-Yi LIU

Pembrolizumab Lung squamous cell carcinoma Severe immune-related ulcerative colitis Adverse drug reactions
Details
Analysis of clinical features of tacrolimus induced acute pancreatitis based on literature cases

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1285-1295.
1308 times 986 times

Chao YE Xin LI Li-Hua LIU Xin HE Shen-Jue CHEN Juan WANG

Tacrolimus Acute pancreatitis Case report Adverse drug reactions Literature analysis
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1275-1284.
1403 times 491 times

Ya-Ping NIU San-Bao CHAI Jing-Zi MA Meng ZHANG Zuo-Xiang LIU Shan-Shan WU Feng SUN

Basal insulin Oral hypoglycemic agents Type 2 diabetes mellitus Poor treatment effect Umbrella review
Details
Optimization of extraction process of Coptidis Rhizoma-Scutellariae Radix based on BP-ANN and CCD-RSM in information entropy theory

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1267-1274.
1336 times 446 times

Bao-Cai WANG Jun-Jiang LI Zhi-Wei XU

Coptidis Rhizoma-Scutellariae Radix BP-ANN CCD-RSM Extraction process Information entropy theory
Details
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1259-1266.
1466 times 528 times

Xi ZHAO Xi YAN Ning LI Chun-Xia HOU

Abemaciclib Fulvestrant Hormone receptor-positive breast cancer Markov model Cost-effectiveness analysis
Details
A retrospective study of potential drug-drug interactions of dabigatran etexilate in a tertiary hospital

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1243-1249.
1307 times 454 times

An-Hua WEI Wen-Jing LI Yan HUANG

Dabigatran etexilate Potential drug-drug interactions Safety Retrospective study
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1238-1242.
1522 times 548 times

Hao-Chun TANG Jun MENG Zheng-Zheng XIA Ling-Zhi REN

Non-small cell lung cancer Pyrotinib Adverse drug reaction Safety Off-indication
Details
Clinical practice guidelines for the use of intravenous polymyxins in children: a protocol

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1231-1237.
1203 times 499 times

Lin TANG Shan SHEN Dong-Na ZOU Bing LENG Rui-Fang NIE Yan JIN Li-Kai LIN Xian-Tao ZENG Suo-Di ZHAI Ling-Li ZHANG Ning HOU

Polymyxins Pediatric medication Anti-infection Guideline protocol
Details
Clinical practice of drug abnormal early warning based on dynamic monitoring of clinical pharmacists

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1225-1230.
1738 times 591 times

Ting-Ting ZHENG Jin LI Lu MAO Ning CHEN Wei ZHANG Jian-Cun ZHEN

Rational drug use Abnormal early warning Dynamic monitoring Clinical pharmacist
Details
Practice and reflection of pharmacovigilance system construction

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1217-1224.
1726 times 637 times

Na WANG Kang-Huai ZHANG

Pharmacovigilance Drug use safety Risk prevention and control Adverse drug reaction Medication error
Details
Poly ADP-ribose polymerase inhibitor-induced thrombocytopenia: recent advances in pathogenesis and treatments

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1209-1216.
1385 times 494 times

Ying-Chen ZHUO Su-Ya ZHANG Peng-Fei SONG Wei-Yi FENG

Poly ADP-ribose polymerase inhibitor Thrombocytopenia Ovarian cancer Adverse drug reaction
Details
Data mining for hypertension associated with VEGFR-TKIs: based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1201-1208.
1662 times 532 times

Xiao-Lan LIAO Jia-Qi GE Hai-Bin ZHU Ting-Ting WU Chun-Xia REN Zi-Cheng YU

Vascular endothelial growth factor receptor-tyrosine kinase inhibitors Hypertension Adverse drug events Pharmacovigilance FAERS database
Details
Analysis of anticoagulant therapy and pharmaceutical care for a patient with obstetrical antiphospholipid syndrome complicated with HELLP syndrome

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):218-223.
1700 times 1459 times

ZHU Yue HUANG Xiaona

Obstetric antiphospholipid syndrome HELLP syndrome Anticoagulant therapy Pregnancy Lactation Pharmaceutical care
Details
Alirocumab in the treatment of hypercholesterolemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1388-1400.
1218 times 480 times

Jian-Cheng ZHOU Chun-Mei JI Wen-Tong FANG Ying ZOU Yong-Qing WANG Yuan-Yuan FU

Alirocumab Hypercholesterolemia Safety Efficacy Cost-effectiveness Rapid health technology assessment
Details
Exploration of linear algebra teaching reform based on the training goal of high-end composite talents

Published on Journal of Mathematical Medicine 2023,36(11):874-880.
1456 times 632 times

Dong-Guo LI Lei GAO Wen-Xin ZHENG Lin LI

Linear algebra Teaching reform Teaching model
Details